Basics Fulgent Genetics, Inc. Fulgent Genetics Inc is a technology company offering genetic testing to provide physicians with clinically actionable diagnostic information used to improve the overall quality of patient care. IPO Date: September 29, 2016 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $859.06M Activated in VL: True Average Daily Range Avg Daily Range: $0.90 | 2.88% Avg Daily Range (30 D): $0.43 | 1.60% Avg Daily Range (90 D): $0.33 | 1.39% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .22M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 40 Avg Trade Size (Sh.) (90 D): 42 Institutional Trades Total Inst.Trades: 1,813 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $1M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.91M Avg Closing Trade (30 D): $1.19M Avg Closing Trade (90 D): $1M Avg Closing Volume: 44.44K     News Aug 1, 2025 @ 8:26 PM Why Fulgent Genetics Stock Was Crushing It on Frid... Source: Eric Volkman Jul 15, 2025 @ 11:41 PM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C. Jul 1, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating GoHea... Source: Bragar Eagel & Squire, P.C. Jun 23, 2025 @ 4:53 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A Jun 10, 2025 @ 1:00 AM Bragar Eagel & Squire, P.C. Is Investigating Semle... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS Diluted EPS Revenue $ 315.55M $ 84.07M $ 81.8M Gross Profit $ 130.14M $ 35.51M $ 34.44M Net Income / Loss $ -44.17M $ -6.83M $ -19.26M Operating Income / Loss $ -70.99M $ -15.35M $ -19.71M Cost of Revenue $ 185.41M $ 48.56M $ 47.37M Net Cash Flow $ 59.6M $ 29.76M $ 20.6M PE Ratio